Blue Trust Inc. trimmed its position in shares of Cardinal Health, Inc. (NYSE:CAH - Free Report) by 40.9% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 3,255 shares of the company's stock after selling 2,248 shares during the quarter. Blue Trust Inc.'s holdings in Cardinal Health were worth $385,000 as of its most recent SEC filing.
Other hedge funds have also recently made changes to their positions in the company. State Street Corp raised its position in shares of Cardinal Health by 4.6% during the third quarter. State Street Corp now owns 14,177,641 shares of the company's stock worth $1,566,913,000 after acquiring an additional 627,253 shares during the last quarter. Geode Capital Management LLC raised its position in shares of Cardinal Health by 0.7% during the third quarter. Geode Capital Management LLC now owns 5,749,859 shares of the company's stock worth $633,298,000 after acquiring an additional 42,082 shares during the last quarter. Pacer Advisors Inc. raised its position in shares of Cardinal Health by 4.7% during the third quarter. Pacer Advisors Inc. now owns 4,290,650 shares of the company's stock worth $474,203,000 after acquiring an additional 191,568 shares during the last quarter. Charles Schwab Investment Management Inc. raised its position in shares of Cardinal Health by 2.3% during the third quarter. Charles Schwab Investment Management Inc. now owns 1,474,625 shares of the company's stock worth $162,976,000 after acquiring an additional 33,388 shares during the last quarter. Finally, Two Sigma Advisers LP raised its position in shares of Cardinal Health by 47.9% during the third quarter. Two Sigma Advisers LP now owns 1,069,462 shares of the company's stock worth $118,197,000 after acquiring an additional 346,362 shares during the last quarter. 87.17% of the stock is owned by institutional investors and hedge funds.
Wall Street Analyst Weigh In
A number of equities analysts have recently issued reports on CAH shares. Wells Fargo & Company raised their price objective on Cardinal Health from $135.00 to $136.00 and gave the stock an "equal weight" rating in a research report on Tuesday, February 4th. Morgan Stanley lifted their target price on Cardinal Health from $136.00 to $142.00 and gave the stock an "overweight" rating in a report on Friday, January 31st. Evercore ISI upgraded Cardinal Health from an "in-line" rating to an "outperform" rating and set a $140.00 target price for the company in a report on Tuesday, January 7th. Mizuho initiated coverage on Cardinal Health in a report on Wednesday, December 4th. They issued an "outperform" rating and a $139.00 target price for the company. Finally, Bank of America upgraded Cardinal Health from a "neutral" rating to a "buy" rating and lifted their target price for the stock from $132.00 to $145.00 in a report on Monday, January 6th. Four equities research analysts have rated the stock with a hold rating and thirteen have given a buy rating to the stock. Based on data from MarketBeat.com, the company presently has an average rating of "Moderate Buy" and an average target price of $136.87.
View Our Latest Stock Report on Cardinal Health
Cardinal Health Trading Down 0.3 %
Cardinal Health stock traded down $0.42 during trading on Friday, hitting $126.96. 2,354,573 shares of the company were exchanged, compared to its average volume of 2,342,976. The business's 50 day moving average is $123.62 and its 200 day moving average is $117.08. Cardinal Health, Inc. has a 52 week low of $93.17 and a 52 week high of $132.84. The company has a market capitalization of $30.67 billion, a P/E ratio of 23.69, a PEG ratio of 1.49 and a beta of 0.63.
Cardinal Health (NYSE:CAH - Get Free Report) last announced its quarterly earnings results on Thursday, January 30th. The company reported $1.93 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.74 by $0.19. Cardinal Health had a negative return on equity of 59.57% and a net margin of 0.59%. Equities analysts expect that Cardinal Health, Inc. will post 7.95 EPS for the current year.
Cardinal Health Announces Dividend
The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, April 15th. Shareholders of record on Tuesday, April 1st will be paid a $0.5056 dividend. The ex-dividend date of this dividend is Tuesday, April 1st. This represents a $2.02 dividend on an annualized basis and a yield of 1.59%. Cardinal Health's dividend payout ratio (DPR) is presently 37.69%.
Cardinal Health Profile
(
Free Report)
Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.
Read More

Before you consider Cardinal Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cardinal Health wasn't on the list.
While Cardinal Health currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.